key: cord-0843675-pq047nkb
authors: Wang, Kaige; Qiu, Zhixin; Liu, Jiasheng; Fan, Tao; Liu, Chunrong; Tian, Panwen; Wang, Ye; Ni, Zhong; Zhang, Shumin; Luo, Jianfei; Liu, Dan; Li, Weimin
title: Analysis of the clinical characteristics of 77 COVID-19 deaths
date: 2020-10-02
journal: Sci Rep
DOI: 10.1038/s41598-020-73136-7
sha: dfb40582aea8db9f2f2c5f6539275a8a7be9990e
doc_id: 843675
cord_uid: pq047nkb

The COVID-19 outbreak is becoming a public health emergency. Data are limited on the clinical characteristics and causes of death. A retrospective analysis of COVID-19 deaths were performed for patients’ clinical characteristics, laboratory results, and causes of death. In total, 56 patients (72.7%) of the decedents (male–female ratio 51:26, mean age 71 ± 13, mean survival time 17.4 ± 8.4 days) had comorbidities. Acute respiratory failure (ARF) and sepsis were the main causes of death. Increases in C-reactive protein (CRP), lactate dehydrogenase (LDH), D-dimer and lactic acid and decreases in lymphocytes were common laboratory results. Intergroup analysis showed that (1) most female decedents had cough and diabetes. (2) The proportion of young- and middle-aged deaths was higher than elderly deaths for males, while elderly decedents were more prone to myocardial injury and elevated CRP. (3) CRP and LDH increased and cluster of differentiation (CD) 4+ and CD8+ cells decreased significantly in patients with hypertension. The majority of COVID-19 decedents are male, especially elderly people with comorbidities. The main causes of death are ARF and sepsis. Most female decedents have cough and diabetes. Myocardial injury is common in elderly decedents. Patients with hypertension are prone to an increased inflammatory index, tissue hypoxia and cellular immune injury.

| (2020) 10:16384 | https://doi.org/10.1038/s41598-020-73136-7

www.nature.com/scientificreports/ 19 according to the WHO interim guidance. Among 79 deaths during this period, two died immediately after admission and were excluded because of a lack of clinical data. Therefore, the clinical and laboratory data of 77 deaths were collected and analysed in this study after the approval of the RHWU Research Ethics Committee (WDRY2020-K068). Informed consent was obtained from Legally Authorized Representative or next to kin of the deceased patients.

Data collection. The epidemiologic, demographic, clinical characteristics, laboratory test and treatment plan data were extracted from electronic medical records in accordance with the modified version of the WHO/ International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) case record form for severe acute respiratory infections. All data were reviewed by two doctors, and then, a third researcher (LD) determined whether there was a difference in interpretation between the two reviewers.

Laboratory test process. The laboratory confirmation method of SARS-CoV-2 infection has been explained in other articles. Real-time RT-PCR assays have been used to detect SARS-CoV-2 in respiratory specimens of patients in other designated hospitals for COVID-19 treatment. Patients with positive results on two assays and pulmonary infection detected by chest CT were confirmed to have COVID-19 and admitted to the RHWU East Branch. After admission, all patients' respiratory specimens were tested again for further diagnosis of SARS-CoV-2 infection. Laboratory tests such as ECG and arterial blood gas analysis and determination of routine complete blood count (CBC), coagulation function, serum biochemical indexes (incl. liver and kidney functions, creatine kinase and lactate dehydrogenase), myocardial enzymes, brain natriuretic peptide, CRP and procalcitonin (PCT) were carried out. In addition, all patients received a chest X-ray or CT scan at least once, and the examination frequency was determined by their doctors.

Definitions. Young Statistical method. Data were analysed by SPSS version 19.0. Normally distributed measurements are expressed as means ± SD. A t-test was used to compare the means of two groups, and ANOVA was used to compare the means of more than two groups. Non-normally distributed measurements are expressed as the median and were analysed by the Wilcoxon rank-sum test. A chi-square, denoted by χ 2 , test was used to analyse enumeration data, and a value of P < 0.05 was considered statistically significant.

Informed consent. For this retrospective study, written informed consent was provided by the subjects' legally authorized ext of kin. The subjects' legally authorized representatives or next of kin provided informed consent for the publication of the manuscript and to publish the data in an online open access publication. Imaging examination. All 77 patients underwent imaging examination (chest X-ray or CT) periodically from disease onset to death. Diffuse lesions (multiple ground-glass opacities likely due to exudate infiltration) in both lungs were found in the early stage and developed into large areas of bilateral lung consolidation, along with bronchiectasis and "white lungs" (asbestosis-like), in the later stage. Spontaneous pneumothorax and subcutaneous and mediastinal emphysema occurred in 2 patients who did not receive mechanical ventilation. www.nature.com/scientificreports/ Table 2 . Initial laboratory analysis of COVID-19 deaths. a The below analysis was done in the cases with the result of cell immunity, so the total number is 53 for all.

Initial laboratory analysis N = 77, n(%), median(IQR)

White blood cell count; × 10 9 /L; normal range 3. www.nature.com/scientificreports/ Intergroup analysis. In this study, intergroup analysis was carried out based on a series of baseline characteristics, including gender, age, survival time and whether comorbid with hypertension, and the results were as follows: (1) Among the initial symptoms of patients who died, females were more prone to cough and dyspnoea (especially in the early stage) , and more likely to have diabetes, while the incidence of sepsis in males seemed to be higher than that in females. In addition, anaemia was more common in females, while elevated levels of CRP, www.nature.com/scientificreports/ creatinine and creatine kinase and decreased levels of platelets and CD4+ cells were more common in males (Fig. 1) . (2) The majority of young and middle-aged deaths (≤ 65 years old) were males. Elderly patients seemed more prone to fatigue and myocardial injury, while young and middle-aged patients were more likely to have elevated levels of alanine aminotransferase and creatine kinase (Fig. 2) . (3) The majority of short-term survival cases were males. In the short-term survival group, symptoms pertaining to the abdomen and nervous system were more likely to be found in the early stage, and the proportion of patients who had heart disease rather than diabetes or chronic lung disease was higher. The incidence of sepsis was higher in this subgroup, and laboratory tests were characterized by decreased platelets and elevated creatine kinase (Fig. 3) . (4) Dyspnoea was more common in deaths complicated with hypertension, while fatigue and neurological symptoms were more common in deaths without hypertension. Compared with deaths without hypertension, CRP and LDH increased, and CD4+ cells and CD8+ cells decreased significantly in deaths complicated with hypertension ( Fig. 4 ; Table 3 ).

A 31-year-old male patient, previously healthy, was admitted to the hospital on February 5, 2020, due to "fever for 13 days and dyspnoea for 2 days". Before onset, he had been exposed to a COVID-19 patient. Oral administration of "oseltamivir 75 mg bid and moxifloxacin 0.5 g qd" was given; however, the effect was poor. The patient had two positive SARS-CoV-2 nucleic acid assays from throat swab specimens conducted by another hospital, and he was transferred to our hospital. Physical examination showed shortness of breath (28 breaths/min), oxygen saturation (by fingertip pulse oximeter) of 75%, and subcutaneous crepitus in the anterior chest along with reduced breath sounds in both lungs. The laboratory values were: leukocyte count: 

This study includes a group of 77 COVID-19 deaths who were diagnosed and developed into critical cases in other hospitals from January to February 2020 and were then admitted to the temporary infection ICU of the RHWU East Branch. The clinical manifestations of this group are very similar to those of SARS-CoV. According to the literature, the shortest time from admission to ARDS is 2 days, and the mortality rate is 15-61.5% 1,6,10 . www.nature.com/scientificreports/ Recent studies have shown that nearly 70% of patients infected with SARS-CoV-2 are men 1, 11 . In this study, men accounted for 66.2% of deaths, which is consistent with other studies. The majority of deaths were in elderly patients (53/77), which is consistent with the conclusion that risk of death increases with age 6 . The majority of both young-and middle-aged deaths and elderly deaths were in male patients, and the male proportion in the former group was comparatively higher than that of the latter. Female deaths were more likely to be complicated with diabetes. Approximately 81.8% of the patients were infected at mass gatherings with no exposure to the Huanan seafood market, which suggests that most of the deaths may be second-generation infected persons. This study shows that fever and respiratory, neurological and digestive symptoms were the common initial clinical manifestations of the patients who died, which is consistent with a previous study 1 . According to Cao Bin's analysis of the first-batch of 191 patients admitted to the ICU, 48% of COVID-19 patients had underlying diseases 6 and that population in our study reached 72.8%. It can be seen that more deaths occur in patients who have underlying diseases. However, there is no relevant research on whether the mortality rate of patients with underlying diseases is higher than that of patients without underlying diseases or how various underlying diseases affect the progression to death. For the first time, a subgroup analysis based on hypertension was conducted in this study.

In terms of laboratory tests, 88% of the patients included in this study had lymphocytopenia, which is a prominent feature of patients with severe SARS-CoV infection because the targeted invasion of SARS-CoV particles can cause the destruction of lymphocytes by destroying their cytoplasmic components 12 . In addition, patients with severe MERS infection also commonly have lymphocytopenia due to lymphocyte apoptosis 13, 14 . Most recent studies have confirmed that lymphocytes in patients with critical COVID-19 decrease significantly compared with lymphocyte counts in patients with mild disease. Some studies have reported that lymphocytopenia is a high-risk factor for death 6 . Others have also shown that the neutrophil-to-lymphocyte ratio (NLR) can be used as a risk factor for the early prediction of critical COVID-19 cases, namely, patients with age ≥ 50 years and NLR ≥ 3.13 are more likely to develop critical disease 15 . The counts of CD4+ cells and CD8+ cells in most patients in this group decrease significantly, but the specific mechanisms of lymphocyte subsets in such diseases needs to be further studied. More than 60% of patients have elevated levels of CRP, LDH and lactic acid, which may be related to the systemic immune response induced by infection and early hypoxia in critical patients. However, the correlation between these indicators and death and their predictive value for death risk need to be further investigated. Consistent with other studies, 77% of patients have increased D-dimer levels and are considered to be in a hypercoagulable state. Furthermore, the risk of thrombosis is increased because of long-term bed rest required by patients with severe disease. Thus, anticoagulant therapy should be actively given. Compared with young-and middle-aged patients who died, elderly decedents are more prone to myocardial injury, which may be related to the fact that elderly patients are more likely to have heart diseases.

ARF is the main cause of death in this group of patients who died, suggesting that SARS-CoV-2 infection mainly affects the respiratory system. Viral interaction with the angiotensin converting enzyme 2 (ACE2) receptor can cause systemic vascular endothelial injury, result in a hypercoagulable state, and cause thrombosis 16, 17 . Most patients in this study had increased D-dimer levels, which also suggests that thrombosis may occur. However, due to the lack of a corresponding examination, the results are unavailable. Recently published autopsy reports 18 on 12 cases of COVID-19 in Germany showed that four patients died of pulmonary embolism and three patients had venous thrombosis, suggesting that pulmonary embolism may be a cause of death in patients with ARF.

A number of studies have reported that coronavirus invades tissues and organs through the ACE2 receptor, which is abundant in the kidney and myocardium; moreover, autopsy results also confirmed that coronavirus can invade myocardial cells 19, 20 . In this study, myocardial injury and acute kidney injury occurred in some patients who died. Whether the injury is caused by SARS-CoV-2 invasion or secondary changes caused by hypoxia is still uncertain. However, it can be determined that myocardial injury and acute kidney injury are not the main causes of death. At present, there are no antiviral drugs, including Kaletra 21 , that are effective for the treatment of COVID-19. Therefore, clinicians should focus on correcting hypoxemia caused by ARDS, maintaining stable vital signs and waiting for the body to eliminate the virus. It has been reported that the proportion of patients requiring mechanical ventilation of critical COVID-19 patients is 30:37 10 . Due to the shortage of medical resources at the time, 40.3% of the patients in this group received mechanical ventilation, and only 9.1% received endotracheal intubation. The time from when patients required endotracheal intubation to when they received it was long enough that some patients could not recover from ARF and eventually died from a lack of oxygen. There are reports that the incidence of pneumothorax in COVID-19 patients is approximately 1-2%, and the incidence in our study reached approximately 2.6% 6, 11 , which is related to the fact that all the patients in this group were severely or critically ill. The aforementioned patient rapidly developed ARF and bilateral spontaneous pneumothorax after the onset of the disease. The cause of spontaneous pneumothorax in this patient may have been the large areas of consolidation in both lungs that resulted in decreased lung compliance, a very high respiratory drive, a vigorous inspiratory effort, and highly negative intrathoracic pressures, leading to pneumothorax 17 and further aggravating the other manifestations of the disease. Therefore, appropriate respiratory support and adequate sedation and analgesia should be given to COVID-19 patients with early-stage ARF. In addition, clinicians should also be mindful of sepsis, the secondary cause of death in this study. Prior studies have shown that bacterial and fungal infections are common in the late stage of virus infection. A total of 30.3% and 16.9% of patients with severe H1N1 flu admitted to the ICU had bacterial or fungal infections, respectively. However, the incidence in COVID-19 patients is still unclear 11, 22, 23 . In this study, there were 7 patients with positive pathogen cultures, 2 of which were fungal pathogens. This result suggests that the incidence of fungal infection in COVID-19 patients may be lower than that of patients with severe H1N1 flu. However, due to the lack of alveolar lavage fluid and other lower respiratory samples, it is impossible to accurately evaluate the incidence of co-infection in COVID-19 patients. The occurrence of secondary bacterial and fungal infections in patients with COVID-19 needs further study.

| (2020) 10:16384 | https://doi.org/10.1038/s41598-020-73136-7

www.nature.com/scientificreports/

The majority of COVID-19 decedents are male, especially elderly decedents with underlying diseases. COVID-19 often starts with cough in female patients, and they are more likely than male COVID-19 patients to have diabetes. The proportion of young-and middle-aged decedents who were male is higher than that among elderly patients. Myocardial injury is common in elderly patients. Dyspnoea, along with a significantly decreased CD4+ cell count, is likely to occur in the early stage of COVID-19 in patients with hypertension. In the short-term survival group, mortality is not significantly associated with whether patients have hypertension; the majority of patients in the short-term survival group are still male and often have heart diseases, and the main cause of death is ARF. Of all 77 deaths, ARF and sepsis were the main causes of death.

Received: 4 April 2020; Accepted: 2 September 2020

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

A novel coronavirus from patients with pneumonia in China

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

The third international consensus definitions for sepsis and septic shock (sepsis-3)

KDIGO clinical practice guidelines for acute kidney injury

National Health Commission of the People's Republic of China

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Multiple organ infection and the pathogenesis of SARS

Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways

T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis

COVID-19 pneumonia: ARDS or not

Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study

Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-nCoV

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

A Trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19

Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections

Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States

W.L and D.L designed the research process; C.L and S.Z analyzed data; K.W and Z.Q wrote the draft; J.L, F.T and Z.N designed synthesis and manuscript editing; K.W, Z.Q, P.T and Y.W performed manuscript revision and editing.

The authors declare no competing interests.

Correspondence and requests for materials should be addressed to J.L., D.L. or W.L.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.